Items where Author is "Karimi, J."

(2022) The Correlation between Coronary Artery Calcium Score with Diagnosis of Angina Pectoris in Patients with and without Metabolic Syndrome, Candidates for Coronary Angiography. Journal of Isfahan Medical School. pp. 759-765. ISSN 10277595 (ISSN)

(2022) Epidemiological Study of Factors Related to the Mortality of Under-Five Years in Isfahan Province in the Years 2018 to 2021. Iranian Journal of Epidemiology. pp. 234-243. ISSN 17357489 (ISSN)

(2022) Frequency Distribution of Causes of Death in Pregnant Women Based on Autopsy Findings in Forensic Medicine in Isfahan Province in 2012-2020. Journal of Isfahan Medical School. pp. 217-222. ISSN 10277595 (ISSN)

(2022) Impact of miRNA-binding site polymorphisms in <i>STAT3</i> gene on occurrence and clinical characteristics of systemic lupus erythematosus. Lupus. pp. 338-346. ISSN 0961-2033

(2022) Impact of miRNA-binding site polymorphisms in STAT3 gene on occurrence and clinical characteristics of systemic lupus erythematosus. LUPUS. pp. 338-346. ISSN 0961-2033 1477-0962 J9 - LUPUS

(2022) T-Score Discordance Between Hip and Spine in Diagnosis of Osteoporosis in Patients From Iranian Population. Acta Medica Iranica. pp. 749-755. ISSN 00446025 (ISSN)

(2020) Protective effects of combined Losartan and Nilotinib on carbon tetrachloride (CCl4)-induced liver fibrosis in rats. Drug and Chemical Toxicology. pp. 468-478. ISSN 0148-0545

(2020) SD1000: High Sustained Viral Response Rate in 1361 Patients With Hepatitis C Genotypes 1, 2, 3, and 4 Using a Low-cost, Fixed-dose Combination Tablet of Generic Sofosbuvir and Daclatasvir: A Multicenter, Phase III Clinical Trial. Clinical Infectious Diseases. pp. 2206-2212. ISSN 1058-4838

(2018) MiR-185 enhances radiosensitivity of colorectal cancer cells by targeting IGF1R and IGF2. Biomedicine & Pharmacotherapy. pp. 763-769. ISSN 0753-3322

(2018) Protective effects of combined Losartan and Nilotinib on carbon tetrachloride (CCl4)-induced liver fibrosis in rats. Drug Chem Toxicol. pp. 1-11. ISSN 1525-6014 (Electronic) 0148-0545 (Linking)

(2018) SD1000: 96.4 SVR12 in 1237 patients with hepatitis C genotypes 1, 2, 3, 4 using co-formulated sofosbuvir/daclatasvir tablets manufactured in Iran - a multicenter phase 3 clinical trial including HIV co-infected, transplant, and hemodialysis patients. Journal of Viral Hepatitis. pp. 198-199. ISSN 1352-0504